Table 1. Demographic and Baseline Characteristics.
| All (n = 52) | United States (n = 20) | Germany (n = 32) | PDifference (US vs German Trials) | |
|---|---|---|---|---|
| Age (years), mean (SEM) | 66.8 (1.1) | 64.0 (2.1) | 68.6 (1.1) | .055 |
| Gender, Female (%) | 18 (34.62) | 12 (60) | 6 (18.75) | .036a |
| Stroke therapy interval (months), mean (SEM) | 59.00 (9.28) | 60.06 (20.01) | 58.34 (8.77) | .93 |
| Stroke location, n (%) | ||||
| Brainstem | 8 (15.38) | 6 (30) | 2 (6.24) | |
| Cortex | 20 (38.46) | 5 (25) | 15 (46.88) | |
| Subcortical | 24 (46.15) | 9 (45) | 15 (46.88) | |
| Right-sided stroke, n (%) | 20 (38.46) | 8 (40) | 12 (37.5) | .86 |
| Lesion volume (mm3 SEM) | 37421.54 (8065.83) | 45775 (11484.75) | 24056 (9717.42) | .16 |
| NIHSS, mean (SEM) | 4.08 (0.35) | 3.67 (0.53) | 4.31 (0.47) | .39 |
Abbreviations: SEM, standard error of the mean; NIHSS, National Institutes of Health Stroke Scale.
a
Indicates significant differences between trials (P < .05).